Supporting Aboriginal Community Controlled Health Services to deliver alcohol care: protocol for a cluster randomised controlled trial.
Adolescent
Adult
Aged
Aged, 80 and over
Alcohol-Related Disorders
/ diagnosis
Australia
Clinical Protocols
Cultural Competency
Delivery of Health Care
/ methods
Female
Health Services, Indigenous
/ organization & administration
Humans
Logistic Models
Male
Middle Aged
Native Hawaiian or Other Pacific Islander
Young Adult
AUDIT-C
Aboriginal
PREVENTIVE MEDICINE
alcohol
health services
screening
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
10 11 2019
10 11 2019
Historique:
entrez:
13
11
2019
pubmed:
13
11
2019
medline:
27
10
2020
Statut:
epublish
Résumé
Indigenous peoples who have experienced colonisation or oppression can have a higher prevalence of alcohol-related harms. In Australia, Aboriginal Community Controlled Health Services (ACCHSs) offer culturally accessible care to Aboriginal and Torres Strait Islander (Indigenous) peoples. However there are many competing health, socioeconomic and cultural client needs. A randomised cluster wait-control trial will test the effectiveness of a model of tailored and collaborative support for ACCHSs in increasing use of alcohol screening (with Alcohol Use Disorders Identification Test-Consumption (AUDIT-C)) and of treatment provision (brief intervention, counselling or relapse prevention medicines). Twenty-two ACCHSs across Australia. Services will be stratified by remoteness, then randomised into two groups. Half receive support soon after the trial starts (intervention or 'early support'); half receive support 2 years later (wait-control or 'late support'). Core support elements will be tailored to local needs and include: support to nominate two staff as champions for increasing alcohol care; a national training workshop and bimonthly teleconferences for service champions to share knowledge; onsite training, and bimonthly feedback on routinely collected data on screening and treatment provision. Primary outcome is use of screening using AUDIT-C as routinely recorded on practice software. Secondary outcomes are recording of brief intervention, counselling, relapse prevention medicines; and blood pressure, gamma glutamyltransferase and HbA1c. Multi-level logistic regression will be used to test the effectiveness of support. Ethical approval has been obtained from eight ethics committees: the Aboriginal Health and Medical Research Council of New South Wales (1217/16); Central Australian Human Research Ethics Committee (CA-17-2842); Northern Territory Department of Health and Menzies School of Health Research (2017-2737); Central Queensland Hospital and Health Service (17/QCQ/9); Far North Queensland (17/QCH/45-1143); Aboriginal Health Research Ethics Committee, South Australia (04-16-694); St Vincent's Hospital (Melbourne) Human Research Ethics Committee (LRR 036/17); and Western Australian Aboriginal Health Ethics Committee (779). ACTRN12618001892202; Pre-results.
Identifiants
pubmed: 31712335
pii: bmjopen-2019-030909
doi: 10.1136/bmjopen-2019-030909
pmc: PMC6858116
doi:
Banques de données
ANZCTR
['ACTRN12618001892202']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e030909Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Alcohol Alcohol. 2016 Sep;51(5):515-21
pubmed: 27337988
Lancet. 2017 Sep 16;390(10100):1345-1422
pubmed: 28919119
Br Med J (Clin Res Ed). 1986 Sep 20;293(6549):735-7
pubmed: 3094634
Med J Aust. 2008 May 5;188(9):525-6
pubmed: 18459924
Aust Health Rev. 2018 Apr;42(2):218-226
pubmed: 28263705
Cochrane Database Syst Rev. 2018 Feb 24;2:CD004148
pubmed: 29476653
Drug Alcohol Rev. 2013 Jan;32(1):72-9
pubmed: 22775591
Addiction. 2003 Dec;98 Suppl 2:31-43
pubmed: 14984240
Med J Aust. 2002 Mar 18;176(6):273-6
pubmed: 11999260
Addict Sci Clin Pract. 2018 Mar 29;13(1):5
pubmed: 29592801
Aust N Z J Public Health. 2010 Feb;34(1):38-44
pubmed: 20920103
Drug Alcohol Rev. 2006 May;25(3):277-87
pubmed: 16753652
Int J Qual Health Care. 2009 Feb;21(1):37-43
pubmed: 18988656
Drug Alcohol Rev. 2003 Mar;22(1):53-9
pubmed: 12745359
J Subst Abuse Treat. 2017 Nov;82:107-112
pubmed: 29021108
Alcohol Clin Exp Res. 2007 Jul;31(7):1208-17
pubmed: 17451397
Addict Sci Clin Pract. 2017 May 10;12(1):14
pubmed: 28490342
Drug Alcohol Rev. 2014 Sep;33(5):482-90
pubmed: 24684618
Med J Aust. 2007 Oct 15;187(8):453-7
pubmed: 17937642
BMC Health Serv Res. 2009 Jul 03;9:114
pubmed: 19575791
Drug Alcohol Depend. 2016 Sep 01;166:254-7
pubmed: 27394934
Trials. 2012 Aug 25;13:149
pubmed: 22920408
Addict Sci Clin Pract. 2014 Sep 01;9:17
pubmed: 25179547
J Stud Alcohol Drugs. 2013 Jul;74(4):598-604
pubmed: 23739024
Am J Prev Med. 2008 Feb;34(2):143-152
pubmed: 18201645
Drug Alcohol Rev. 2012 Jan;31(1):13-9
pubmed: 21426422
Drug Alcohol Depend. 2015 Feb 1;147:116-21
pubmed: 25533894
Can J Psychiatry. 2000 Sep;45(7):607-16
pubmed: 11056823
Addiction. 2015 Dec;110(12):1877-900
pubmed: 26234486